Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital

被引:21
作者
Baang, Ji Hoon [1 ]
Axelrod, Peter [1 ]
Decker, Brooke K. [2 ]
Hujer, Andrea M. [3 ,4 ]
Dash, Georgia [5 ]
Truant, Allan R. [1 ]
Bonomo, Robert A. [3 ,4 ]
Fekete, Thomas [1 ]
机构
[1] Temple Univ, Sch Med, Infect Dis Sect, Philadelphia, PA 19122 USA
[2] Univ Hosp Case Med Ctr, Dept Internal Med, Cleveland, OH USA
[3] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA
[4] Case Western Sch Med, Dept Med, Cleveland, OH USA
[5] Cape Cod Healthcare, Hyannis, MA USA
基金
美国国家卫生研究院;
关键词
Multidrug-resistant bacteria; Surgical intensive care unit; Rep-PCR; Outbreak; Molecular typing; PSEUDOMONAS-AERUGINOSA; MOLECULAR EPIDEMIOLOGY; KLEBSIELLA-PNEUMONIAE; RAPID SPREAD; RISK-FACTORS; NEW-YORK; BAUMANNII; INFECTIONS; OUTBREAK; COLONIZATION;
D O I
10.1016/j.ajic.2011.04.326
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Background: Acinetobacter species are well-known causes of health careeassociated infections. The longitudinal epidemiology of this species in the hospital setting is poorly understood. A sudden, persistent increase in multidrug-resistant (MDR) A baumannii infections occurred beginning in June 2006 at Temple University Hospital in Philadelphia. An analysis was done to describe the longitudinal molecular epidemiology of MDR A baumannii in a tertiary care hospital. Methods: This was an epidemiologic investigation using repetitive extragenic palindromic-PCR (rep-PCR) of patients with a positive culture for MDR A baumannii admitted to the hospital between February 2006 and January 2010. MDR A baumannii were defined as susceptible only to colistin and/or tigecycline. Results: The incidence rate of MDR A baumannii rose from 0.36 cases per 1,000 patient-days (pre-epidemic) to 0.86 cases per 1,000 patient-days, due mainly to an increase in the surgical intensive care unit. Enhanced infection control measures were implemented, but waves of MDR A baumannii continued to be documented through routine surveillance. Of 32 strains collected in 2006-2007, a single predominant clone and 2 minor clones accounted for almost all of the cases of MDR A baumannii studied. Of 24 strains collected in 2008-2009, another clone, different from those studied in the earlier period, predominated, and was accompanied by 3 minor variants. Conclusion: Following an outbreak in the surgical intensive care unit, MDR A baumannii persisted in our institution for a 3-year period despite rigorous infection control measures. An unexpected strain replacement occurred during this period, with the original predominant strain disappearing completely and new minor clones displacing the original minor clones. Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.
引用
收藏
页码:134 / 137
页数:4
相关论文
共 19 条
[1]
A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center:: A 3-year study [J].
Apisarnthanarak, Anucha ;
Pinitchai, Uayporn ;
Thongphubeth, Kanokporn ;
Yuekyen, Chananart ;
Warren, David K. ;
Fraser, Victoria J. .
CLINICAL INFECTIOUS DISEASES, 2008, 47 (06) :760-767
[2]
Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[3]
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].
Bratu, S ;
Landman, D ;
Haag, R ;
Recco, R ;
Eramo, A ;
Alam, M ;
Quale, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435
[4]
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents [J].
Brown, S ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) :326-329
[5]
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Montero, A ;
Pujol, M ;
Domínguez, MA ;
Ayats, J ;
Argerich, MJ ;
Garrigosa, F ;
Ariza, J ;
Gudiol, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4086-4095
[6]
An outbreak of Acinetobacter baumannii:: The importance of cross-transmission [J].
D'Agata, EMC ;
Thayer, V ;
Schaffner, W .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (09) :588-591
[7]
Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients:: A cohort study [J].
García-Garmendia, JL ;
Ortiz-Leyba, C ;
Garnacho-Montero, J ;
Jiménez-Jiménez, FJ ;
Pérez-Paredes, C ;
Barrero-Almodóvar, AE ;
Gili-Miner, M .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) :939-946
[8]
CLINICAL AND MOLECULAR EPIDEMIOLOGY OF ACINETOBACTER INFECTIONS SENSITIVE ONLY TO POLYMYXIN-B AND SULBACTAM [J].
GO, ES ;
URBAN, C ;
BURNS, J ;
KREISWIRTH, B ;
EISNER, W ;
MARIANO, N ;
MOSINKASNIPAS, K ;
RAHAL, JJ .
LANCET, 1994, 344 (8933) :1329-1332
[9]
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY -: The preantibiotic era has returned [J].
Landman, D ;
Quale, JM ;
Mayorga, D ;
Adedeji, A ;
Vangala, K ;
Ravishankar, J ;
Flores, C ;
Brooks, S .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (13) :1515-1520
[10]
The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York [J].
Lomaestro, BM ;
Tobin, EH ;
Shang, WC ;
Gootz, T .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) :E26-E28